img

Global Gene Therapy Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapy Drugs Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Gene Therapy Drugs Market
The global Gene Therapy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Gene Therapy Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Gene Therapy Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Gene Therapy Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Gene Therapy Drugs include F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Gene Therapy Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Gene Therapy Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Therapy Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Therapy Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Gene Therapy Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Gene Therapy Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc.



By Company


F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical，Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics
Segment by Type
Neuromuscular Disease
Genetic Disease
Other

Segment by Application


Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Gene Therapy Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Gene Therapy Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy Drugs revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Neuromuscular Disease
1.2.3 Genetic Disease
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Therapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Drugs Market Perspective (2018-2034)
2.2 Global Gene Therapy Drugs Growth Trends by Region
2.2.1 Gene Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Gene Therapy Drugs Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapy Drugs Forecasted Market Size by Region (2024-2034)
2.3 Gene Therapy Drugs Market Dynamics
2.3.1 Gene Therapy Drugs Industry Trends
2.3.2 Gene Therapy Drugs Market Drivers
2.3.3 Gene Therapy Drugs Market Challenges
2.3.4 Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy Drugs by Players
3.1.1 Global Gene Therapy Drugs Revenue by Players (2018-2024)
3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2022
3.5 Global Key Players of Gene Therapy Drugs Head office and Area Served
3.6 Global Key Players of Gene Therapy Drugs, Product and Application
3.7 Global Key Players of Gene Therapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Drugs Breakdown Data by Type
4.1 Global Gene Therapy Drugs Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034)
5 Gene Therapy Drugs Breakdown Data by Application
5.1 Global Gene Therapy Drugs Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Gene Therapy Drugs Market Size (2018-2034)
6.2 North America Gene Therapy Drugs Market Size by Type
6.2.1 North America Gene Therapy Drugs Market Size by Type (2018-2024)
6.2.2 North America Gene Therapy Drugs Market Size by Type (2024-2034)
6.2.3 North America Gene Therapy Drugs Market Share by Type (2018-2034)
6.3 North America Gene Therapy Drugs Market Size by Application
6.3.1 North America Gene Therapy Drugs Market Size by Application (2018-2024)
6.3.2 North America Gene Therapy Drugs Market Size by Application (2024-2034)
6.3.3 North America Gene Therapy Drugs Market Share by Application (2018-2034)
6.4 North America Gene Therapy Drugs Market Size by Country
6.4.1 North America Gene Therapy Drugs Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Gene Therapy Drugs Market Size by Country (2018-2024)
6.4.3 North America Gene Therapy Drugs Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy Drugs Market Size (2018-2034)
7.2 Europe Gene Therapy Drugs Market Size by Type
7.2.1 Europe Gene Therapy Drugs Market Size by Type (2018-2024)
7.2.2 Europe Gene Therapy Drugs Market Size by Type (2024-2034)
7.2.3 Europe Gene Therapy Drugs Market Share by Type (2018-2034)
7.3 Europe Gene Therapy Drugs Market Size by Application
7.3.1 Europe Gene Therapy Drugs Market Size by Application (2018-2024)
7.3.2 Europe Gene Therapy Drugs Market Size by Application (2024-2034)
7.3.3 Europe Gene Therapy Drugs Market Share by Application (2018-2034)
7.4 Europe Gene Therapy Drugs Market Size by Country
7.4.1 Europe Gene Therapy Drugs Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Gene Therapy Drugs Market Size by Country (2018-2024)
7.4.3 Europe Gene Therapy Drugs Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy Drugs Market Size (2018-2034)
8.2 China Gene Therapy Drugs Market Size by Type
8.2.1 China Gene Therapy Drugs Market Size by Type (2018-2024)
8.2.2 China Gene Therapy Drugs Market Size by Type (2024-2034)
8.2.3 China Gene Therapy Drugs Market Share by Type (2018-2034)
8.3 China Gene Therapy Drugs Market Size by Application
8.3.1 China Gene Therapy Drugs Market Size by Application (2018-2024)
8.3.2 China Gene Therapy Drugs Market Size by Application (2024-2034)
8.3.3 China Gene Therapy Drugs Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Gene Therapy Drugs Market Size (2018-2034)
9.2 Asia Gene Therapy Drugs Market Size by Type
9.2.1 Asia Gene Therapy Drugs Market Size by Type (2018-2024)
9.2.2 Asia Gene Therapy Drugs Market Size by Type (2024-2034)
9.2.3 Asia Gene Therapy Drugs Market Share by Type (2018-2034)
9.3 Asia Gene Therapy Drugs Market Size by Application
9.3.1 Asia Gene Therapy Drugs Market Size by Application (2018-2024)
9.3.2 Asia Gene Therapy Drugs Market Size by Application (2024-2034)
9.3.3 Asia Gene Therapy Drugs Market Share by Application (2018-2034)
9.4 Asia Gene Therapy Drugs Market Size by Region
9.4.1 Asia Gene Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Gene Therapy Drugs Market Size by Region (2018-2024)
9.4.3 Asia Gene Therapy Drugs Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Gene Therapy Drugs Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Gene Therapy Drugs Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Details
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2018-2024)
11.1.5 F. Hoffmann-La Roche AG Recent Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Gene Therapy Drugs Introduction
11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2018-2024)
11.2.5 Novartis International AG Recent Developments
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Company Details
11.3.2 Gilead Sciences, Inc. Business Overview
11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2018-2024)
11.3.5 Gilead Sciences, Inc. Recent Developments
11.4 Ultragenyx Pharmaceutical，Inc.
11.4.1 Ultragenyx Pharmaceutical，Inc. Company Details
11.4.2 Ultragenyx Pharmaceutical，Inc. Business Overview
11.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Introduction
11.4.4 Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2018-2024)
11.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2018-2024)
11.5.5 Applied Genetic Technologies Corp Recent Developments
11.6 Audentes Therapeutics
11.6.1 Audentes Therapeutics Company Details
11.6.2 Audentes Therapeutics Business Overview
11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024)
11.6.5 Audentes Therapeutics Recent Developments
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Company Details
11.7.2 BioMarin Pharmaceutical Business Overview
11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2018-2024)
11.7.5 BioMarin Pharmaceutical Recent Developments
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2018-2024)
11.8.5 Bluebird Bio Recent Developments
11.9 Nightstar Therapeutics
11.9.1 Nightstar Therapeutics Company Details
11.9.2 Nightstar Therapeutics Business Overview
11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024)
11.9.5 Nightstar Therapeutics Recent Developments
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Details
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024)
11.10.5 Sangamo Therapeutics Recent Developments
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Details
11.11.2 Spark Therapeutics Business Overview
11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024)
11.11.5 Spark Therapeutics Recent Developments
11.12 uniQure
11.12.1 uniQure Company Details
11.12.2 uniQure Business Overview
11.12.3 uniQure Gene Therapy Drugs Introduction
11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2018-2024)
11.12.5 uniQure Recent Developments
11.13 VBL Therapeutics
11.13.1 VBL Therapeutics Company Details
11.13.2 VBL Therapeutics Business Overview
11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024)
11.13.5 VBL Therapeutics Recent Developments
11.14 Voyager Therapeutics
11.14.1 Voyager Therapeutics Company Details
11.14.2 Voyager Therapeutics Business Overview
11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024)
11.14.5 Voyager Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Neuromuscular Disease
Table 3. Key Players of Genetic Disease
Table 4. Key Players of Other
Table 5. Global Gene Therapy Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Gene Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Gene Therapy Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Gene Therapy Drugs Market Share by Region (2018-2024)
Table 9. Global Gene Therapy Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Gene Therapy Drugs Market Share by Region (2024-2034)
Table 11. Gene Therapy Drugs Market Trends
Table 12. Gene Therapy Drugs Market Drivers
Table 13. Gene Therapy Drugs Market Challenges
Table 14. Gene Therapy Drugs Market Restraints
Table 15. Global Gene Therapy Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Gene Therapy Drugs Revenue Share by Players (2018-2024)
Table 17. Global Top Gene Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2022)
Table 18. Global Gene Therapy Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Gene Therapy Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Gene Therapy Drugs, Headquarters and Area Served
Table 21. Global Key Players of Gene Therapy Drugs, Product and Application
Table 22. Global Key Players of Gene Therapy Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Gene Therapy Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Gene Therapy Drugs Revenue Share by Application (2018-2024)
Table 30. Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Gene Therapy Drugs Revenue Share by Application (2024-2034)
Table 32. North America Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Gene Therapy Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Gene Therapy Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Gene Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Gene Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Gene Therapy Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Gene Therapy Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Gene Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Gene Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Gene Therapy Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Gene Therapy Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Gene Therapy Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Gene Therapy Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Gene Therapy Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Gene Therapy Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Gene Therapy Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gene Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 64. F. Hoffmann-La Roche AG Company Details
Table 65. F. Hoffmann-La Roche AG Business Overview
Table 66. F. Hoffmann-La Roche AG Gene Therapy Drugs Product
Table 67. F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 68. F. Hoffmann-La Roche AG Recent Developments
Table 69. Novartis International AG Company Details
Table 70. Novartis International AG Business Overview
Table 71. Novartis International AG Gene Therapy Drugs Product
Table 72. Novartis International AG Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 73. Novartis International AG Recent Developments
Table 74. Gilead Sciences, Inc. Company Details
Table 75. Gilead Sciences, Inc. Business Overview
Table 76. Gilead Sciences, Inc. Gene Therapy Drugs Product
Table 77. Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 78. Gilead Sciences, Inc. Recent Developments
Table 79. Ultragenyx Pharmaceutical，Inc. Company Details
Table 80. Ultragenyx Pharmaceutical，Inc. Business Overview
Table 81. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product
Table 82. Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 83. Ultragenyx Pharmaceutical，Inc. Recent Developments
Table 84. Applied Genetic Technologies Corp Company Details
Table 85. Applied Genetic Technologies Corp Business Overview
Table 86. Applied Genetic Technologies Corp Gene Therapy Drugs Product
Table 87. Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 88. Applied Genetic Technologies Corp Recent Developments
Table 89. Audentes Therapeutics Company Details
Table 90. Audentes Therapeutics Business Overview
Table 91. Audentes Therapeutics Gene Therapy Drugs Product
Table 92. Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 93. Audentes Therapeutics Recent Developments
Table 94. BioMarin Pharmaceutical Company Details
Table 95. BioMarin Pharmaceutical Business Overview
Table 96. BioMarin Pharmaceutical Gene Therapy Drugs Product
Table 97. BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 98. BioMarin Pharmaceutical Recent Developments
Table 99. Bluebird Bio Company Details
Table 100. Bluebird Bio Business Overview
Table 101. Bluebird Bio Gene Therapy Drugs Product
Table 102. Bluebird Bio Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 103. Bluebird Bio Recent Developments
Table 104. Nightstar Therapeutics Company Details
Table 105. Nightstar Therapeutics Business Overview
Table 106. Nightstar Therapeutics Gene Therapy Drugs Product
Table 107. Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 108. Nightstar Therapeutics Recent Developments
Table 109. Sangamo Therapeutics Company Details
Table 110. Sangamo Therapeutics Business Overview
Table 111. Sangamo Therapeutics Gene Therapy Drugs Product
Table 112. Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 113. Sangamo Therapeutics Recent Developments
Table 114. Spark Therapeutics Company Details
Table 115. Spark Therapeutics Business Overview
Table 116. Spark Therapeutics Gene Therapy Drugs Product
Table 117. Spark Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 118. Spark Therapeutics Recent Developments
Table 119. uniQure Company Details
Table 120. uniQure Business Overview
Table 121. uniQure Gene Therapy Drugs Product
Table 122. uniQure Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 123. uniQure Recent Developments
Table 124. VBL Therapeutics Company Details
Table 125. VBL Therapeutics Business Overview
Table 126. VBL Therapeutics Gene Therapy Drugs Product
Table 127. VBL Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 128. VBL Therapeutics Recent Developments
Table 129. Voyager Therapeutics Company Details
Table 130. Voyager Therapeutics Business Overview
Table 131. Voyager Therapeutics Gene Therapy Drugs Product
Table 132. Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2018-2024) & (US$ Million)
Table 133. Voyager Therapeutics Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Gene Therapy Drugs Market Share by Type: 2022 VS 2034
Figure 3. Neuromuscular Disease Features
Figure 4. Genetic Disease Features
Figure 5. Other Features
Figure 6. Global Gene Therapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Gene Therapy Drugs Market Share by Application: 2022 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Gene Therapy Drugs Report Years Considered
Figure 11. Global Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Gene Therapy Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Gene Therapy Drugs Market Share by Region: 2022 VS 2034
Figure 14. Global Gene Therapy Drugs Market Share by Players in 2022
Figure 15. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2022
Figure 17. North America Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Gene Therapy Drugs Market Share by Type (2018-2034)
Figure 19. North America Gene Therapy Drugs Market Share by Application (2018-2034)
Figure 20. North America Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 21. United States Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Gene Therapy Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 24. Europe Gene Therapy Drugs Market Share by Type (2018-2034)
Figure 25. Europe Gene Therapy Drugs Market Share by Application (2018-2034)
Figure 26. Europe Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 27. Germany Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. China Gene Therapy Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 34. China Gene Therapy Drugs Market Share by Type (2018-2034)
Figure 35. China Gene Therapy Drugs Market Share by Application (2018-2034)
Figure 36. Asia Gene Therapy Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 37. Asia Gene Therapy Drugs Market Share by Type (2018-2034)
Figure 38. Asia Gene Therapy Drugs Market Share by Application (2018-2034)
Figure 39. Asia Gene Therapy Drugs Market Share by Region (2018-2034)
Figure 40. Japan Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. South Korea Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. China Taiwan Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Southeast Asia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. India Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Australia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Gene Therapy Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gene Therapy Drugs Market Share by Type (2018-2034)
Figure 48. Middle East, Africa, and Latin America Gene Therapy Drugs Market Share by Application (2018-2034)
Figure 49. Middle East, Africa, and Latin America Gene Therapy Drugs Market Share by Country (2018-2034)
Figure 50. Brazil Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Mexico Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Turkey Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Israel Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. GCC Countries Gene Therapy Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. F. Hoffmann-La Roche AG Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 57. Novartis International AG Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 58. Gilead Sciences, Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 59. Ultragenyx Pharmaceutical，Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 60. Applied Genetic Technologies Corp Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 61. Audentes Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 62. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 63. Bluebird Bio Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 64. Nightstar Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 65. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 66. Spark Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 67. uniQure Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 68. VBL Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 69. Voyager Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries